Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 10,000 shares at $30.02 ($300K) on 2022-07-13, disclosed to the SEC on 2022-07-14.
Open-market sale of $300k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 1,710 | $51K | 17.1% |
| 2 | $30.02 | 1,710 | $51K | 17.1% |
| 3 | $30.01 | 3,290 | $99K | 32.9% |
| 4 | $30.01 | 3,290 | $99K | 32.9% |
| Total | $30.01 avg | 10,000 | $300K | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |